John Vander Mosten
Analyst
Analyst — Zax SCR
Earnings-call appearances
-
Protalix Biotherapeutics Second Quarter 2026 Financial and Business Results Conference Call2026-08-12
Protalix BioTherapeutics, Inc. (PLX)